Different lasers and techniques for proliferative diabetic retinopathy

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 8, 2016, Pages

  Moutray, Tanya ^a   Evans, Jennifer R ^b   Armstrong, David J ^c   Azuara Blanco, Augusto ^d  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON PLASMA COAGULATION; CENTRAL MACULAR THICKNESS; CLINICAL EFFECTIVENESS; DRIVER LICENCE; EYE BURN; EYE PAIN; HUMAN; LASER COAGULATION; LASER SAFETY; MACULAR EDEMA; OPHTHALMIC ARGON LASER; OPHTHALMIC LASER; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA DETACHMENT; REVIEW; SYSTEMATIC REVIEW; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 84981276322     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012314     Document Type: Review

References (27)

1. Al-Hussainy S, Dodson PM, Gibson JM. Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye 2008;22(1):96-9.
2. Castillejos-Rios D, Devenyl R, Moffat K, Yu E. Dye yellow vs argon green laser in panretinal photocoagulation for proliferative diabetic retinopathy: a comparison of minimum power requirements. Canadian Journal Ophthalmology 1992;27(5):243-4.
3. Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation, 2015. Available at www.covidence.org.
4. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine 1993;329(14):977-86.
5. Doft B, Blankenship G. Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1982;89(7):772-9.
6. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978;85(1):82-106.
7. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981;88(7):583-600.
8. ETDRS Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study Research Group. Archives of Ophthalmology 1985;103(12):1796-1806.
9. ETDRS Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1987;84(7):761-74.
10. ETDRS Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):766-85.
11. Evans JR, Michelessi M, Virgili G. Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD011234.pub2]
12. Feman SS. Diabetes and the eye. In: Tasman W, Jaeger EA editor(s). Duane's Clinical Ophthalmology. Vol. 5, Philadelphia, PA: Lippincott Williams & Wilkins, 2004.
13. Geiss LS, Cowie C. Type 2 diabetes and persons at high risk of diabetes. In: Venkat Narayan KM, Williams D, Gregg EW, Cowie C editor(s). Diabetes Public Health: from Data to Policy. New York, NY: Oxford University Press, 2011:15-32.
14. Ghanchi F, Diabetic Retinopathy Guidelines Working Group. The Royal College of Ophthalmologists' clinical guidelines for diabetic retinopathy: a summary. Eye 2013;27(2):285-7.
15. Ghosh F, Gjorloff K. Protein kinase C expression in the rabbit retina after laser photocoagulation. Graefe's Archive for Clinical and Experimental Ophthalmology 2005;243(8):803-10.
16. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
17. McMaster University. Available from www.gradepro.org. GRADEpro. McMaster University. Available from www.gradepro.org, 2014.
18. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiology 2007;14(4):179-83.
19. Luttrull JK, Spink CJ. Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema. Ophthalmic Surgery, Lasers and Imaging 2006;37(5):370-7.
20. Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, et al. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy. Archives of Ophthalmology 2010;128(5):525-33.
21. Muraly P, Limbad P, Srinivasan K, Ramasamy K. Single session of PASCAL versus multiple sessions of conventional laser for panretinal photocoagulation in proliferative diabetic retinopathy: a comparative study. Retina 2011;31(7):1359-65.
22. Pollack JS, Kim JE, Pulido JS, Burke JM. Tissue effects of subclinical diode laser treatment of the retina. Archives of Ophthalmology 1998;116(12):1633-9.
23. Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N, et al. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation. Health Technology Assessment 2015; Vol. 19, issue 51:1-247.
24. Stefánsson E. The therapeutic effects of retinal laser treatment and vitrectomy: a theory based on oxygen and vascular physiology. Acta Ophthalmologica Scandinavica 2001;79(5):435-40.
25. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006;49(8):1761-9.
26. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. The Lancet 1998;352(9131):837-53.
27. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35(3):556-64.